Tavapadon aims to treat Parkinson’s motor symptoms by mimicking dopamine in a once-a-day oral dose. And the pivotal, ...

The company plans to submit a new drug application for tavapadon to the US Food and Drug Administration next year.

we could identify individuals with specific deficiencies and administer oral riboflavin and biotin supplements to those with ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

AbbVie's experimental drug to treat early Parkinson's disease helped significantly improve patients' ability to carry out ...

Intra-Cellular Therapies is developing Lenrispodun for the treatment of patients with Parkinson's Disease in a phase 2 study.

Two teams of scientists have recently come up with potential breakthroughs with preventing a serious side effect of Parkinson ...

Centogene NV and ROPAD consortium publish data from a landmark study identifying genetic variants that may respond to ...

Treatment with tavapadon led to a statistically significant improvement in motor function compared with placebo. Topline results were announced from a phase 3 trial evaluating tavapadon, a selective ...

A Risky Business: Why Do Some Parkinson's Disease Treatments Affect Decision Making? Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system disorder, is treated with medications that ...

A decline in motor skills is a hallmark of Parkinson's disease, regularly taking the form of slowness, rigidity, and tremors.

Bobbi Conner talks with MUSC's Dr. Vanessa Hinson about what causes Parkinson’s disease and what can be done to reduce the ...